complex drugs : Latest News, Videos and Photos | Outlook Business
Home » Search
Search Result : "complex drugs"

Benchmark return tends to camouflage Changing sector composition

While the new law regarding related-party transactions is a welcome step, implementing it will be a challenge

WhiteHat Jr is on a mission to make complex coding as easy as child’s play

Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?

Generic Indian pharma players are changing their formula to focus on high-margin complex generics and specialty drugs

The Indian pharma industry has a stellar decadal run and it’s not going to change anytime soon

A strong product pipeline and receding US FDA threat could well turn the tide in favour of the beleaguered pharma players

Lupin is betting on its specialty drugs business to counter the pricing pressures in the US generics market 

Not content with the initial win in biosimiliars, Kiran Mazumdar-Shaw is pushing new frontiers in biologics

Regulatory woes continue to pile up for pharma companies

The GST regime could be the answer to India’s complex logistics network

Mumbai's diamond bourse at Bandra Kurla Complex is all set to lose out business to Surat

Impulse Social Enterprises is ensuring sustainable livelihoods in the northeast

Abysmal infrastructure and competition from nearby clusters are choking Jalandhar units

Its relative inexperience and lack of enough real estate to spread out is costing Mancheswar dear

Drug majors are shifting clinical trials out of India as lawmakers turn on the heat

Dr Reddy's is adapting to industry dynamics and seizing opportunities while staying true to the founder’s vision

He has tirelessly fought against a monopoly in life-saving drugs. Fighting alone has failed to dissuade him

The Ambur cluster is weathering power cuts and strict pollution control norms

Tectonic changes in the US generic drugs market is causing  huge shifts in Indian pharma’s strategies as well